Osteoporosis: diagnostic testing, interpretation, and correlations with oral health--implications for dentistry.
Osteoporosis affects over 10 million Americans, including over 2 million men. Dentistry is in a position to work alongside medicine to assist the population in preventing and coping with this condition. This article provides an overview of osteoporosis, including its causes, assessment, prevention, and treatment. Various pharmacologic agents are reviewed, including bisphosphonates, selective estrogen receptor modulators, calcitonin, anabolic agents, and fluoride. The article also discusses the dentist's role in prevention, risk assessment, diagnosis, nutrition counseling, and evaluating the impact of the disease and its treatment on dental management and treatment planning. As dental implants become more in demand, the prognosis for and potential complications of implant therapy in patients with osteoporosis are a matter of intense interest.
Mulligan
Roseann
R
University of Southern California, School of Dentistry, 925 West 34th Street, Los Angeles, CA 90089-0641, USA. mulligan@usc.edu
Sobel
Stephen
S
D000368:Aged; D045930:Anabolic Agents / Q000627:therapeutic use; D002116:Calcitonin / Q000627:therapeutic use; D015921:Dental Implants; D004164:Diphosphonates / Q000627:therapeutic use; D005260:Female; D005459:Fluorides / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009909:Oral Health; D010024:Osteoporosis / Q000000981:diagnostic imaging* / Q000517:prevention & control; D011859:Radiography; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use
D045930:Anabolic Agents; D015921:Dental Implants; D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators; D002116:Calcitonin; D005459:Fluorides